I did this in the past at thought some of you might be interested.
At some point in the past you used an online resource called the Chronic Myelogenous Leukemia Profiler Tool. At the time you registered for this treatment decision tool, you indicated that you would be interested in being contacted by NexCura, which operates the Chronic Myelogenous Leukemia Tool, about opportunities to participate in market research. We recognize that dealing with cancer can be a difficult experience and that you may not want to participate in market research. If that is the case, please delete this e-mail. We thought you would like to know that there is a research group recruiting men and women with Chronic Myelogenous Leukemia (CML) to participate in a series of online discussions/bulletin board activities over the course of about 7 days during the week of February 9th. Each day you will receive a new activity which will take approximately 15-minutes to complete (About a 2-hour total commitment throughout the week). The research group is offering $150 to each qualified patient who participates in the study. If you'd like to find out if you qualify, please take this brief (approximately 10 questions) screener by clicking here. If the link does not work, please paste the following into your browser window: https://Survey.Nexcura.com/Survey.aspx?rg=68B62AAE-1579-4FCD-ABE4-086FE7DE384A Any one of these questions may disqualify you from participation, but you may be asked all 10 questions before finding out if you qualify to participate in the interviews. All data collected (if qualified) will be passed on to the market research group hosting the study. If you qualify, the market research group may contact you for an interview. You will not be paid for just taking the online screener - you will only be paid if you participate in the interviews. This study is strictly for research purposes only. Your individual answers will be kept completely confidential, and any personal information you provide will not be shared with others. Participation in these research interviews is limited and there may be additional criteria needed to participate. If you wish to share this opportunity with others who may be eligible in your area, please have them contact NexCura toll-free at 1-877-422-3228. -------------------------------------------------------------------------------- Questions about this research? You may contact us at: Email: intervi...@education.nexcura.com 1-877-422-3228 Patient Information Services NexCura, a Thomson Reuters healthcare business 1215 4th Avenue, Suite 1925 Seattle, WA 98161 If you wish to review NexCura's Privacy Statement, visit: http://www.nexcura.com/nexcura/Nexcura_Privacy.asp -------------------------------------------------------------------------------- You have received this e-mail as a result of your request for information when you registered with NexCura, Inc. You may unsubscribe from this e-mail notification service at any time by going to the following page: http://www.nexcura.com/EU.asp?ESubId=B183F088F90447F5A815ABD56A1DA91E_%26%25%23bc%23%26%27 NexCura will not release your e-mail address or other personally identifying information. --~--~---------~--~----~------------~-------~--~----~ [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to CMLHope@googlegroups.com To unsubscribe from this group, send email to cmlhope-unsubscr...@googlegroups.com For more options, visit this group at http://groups.google.com/group/CMLHope -~----------~----~----~----~------~----~------~--~---
